Engineers Gate Manager LP Seagen Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $297,188 - $395,701	2,197 Added 104.92%	4,291 $587,000
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $227,848 - $375,517	2,094 New	2,094 $371,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $239,173 - $285,127	-1,679 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $868,969 - $1.04 Million	-6,433 Reduced 79.3%	1,679 $265,000
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $275,845 - $382,744	-2,006 Reduced 19.83%	8,112 $1.13 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $1.67 Million - $2.14 Million	10,118 New	10,118 $1.77 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.